Head of Ophthalmology Medical Affairs

Regeneron is a global leader and pioneer in ophthalmology research and has market-leading drugs for the treatment of retinal diseases. The Eylea brand is approved for the treatment of several retinal disorders and is the market category leader in the anti-vascular endothelial growth factor (anti-VEGF) class for these disorders. Beyond Eylea, Regeneron is committed to research with other mechanisms of actions and modalities for the treatment of a variety of other ophthalmological disorders. Regeneron Global Medical Affairs is organized in an optimally aligned matrix structure for the delivery of therapeutic and functional area expertise. Our medical affairs physicians and scientists are experts on our medicines and form an extremely valuable part of our global development organization. They serve as important contacts between Regeneron and the scientific and healthcare community.

The Head of Medical Affairs for Ophthalmology will report to the Head of Internal Medicine for Medical Affairs with primary responsibility to lead and ensure successful execution of all relevant medical affairs programs and functions associated with ophthalmology assets in clinical development, and marketed products in the ophthalmology Global Medical Franchise at Regeneron. In addition to leading the strategy and executional elements of phase IV (post-marketing) and investigator-initiated studies, the role includes being a thought partner with clinical development colleagues for the purpose of driving innovative development strategies, as well as being a collaborator with commercial colleagues, helping to ensure commercial strategies benefit from the medical insight of an experienced team of clinicians.

This senior role provides day to day people leadership to a growing team responsible for the planning and execution of medical affairs studies, programs and projects supporting development activities and commercialization needs for ophthalmology products and assets. This individual will be a key representative of Medical Affairs to a range of audiences, including executive leadership, development partners, and will be a member of the Global Development Strategic Project Team. This individual will play a critical role in defining and maintaining optimal professional relationship with the Medical Affairs leadership of our alliance partner(s) where appropriate.

A typical day for the Head of Medical Affairs, Ophthalmology will include:

• Provide deep therapeutic area subject matter expertise to an expanding and advancing ophthalmology portfolio that will cover many molecules, and several therapeutic platforms.

• Collaborate and provide sound therapeutic area subject matter expertise to key stakeholders across Regeneron (and alliance partners as needed) including internal ophthalmology scientific colleagues, the Strategic Program Teams, as well as colleagues responsible for commercial strategies.
• Oversee and lead Medical Impact Teams to develop and evolve a long-term medical vision for the asset/indication, formulate Medical Impact Plans aligned with the medical vision and synthesize and share insights to inform decision-making at the program level.
• Ensure that scientific rigor and innovation continues to be integrated into all medical affairs-related development and commercialization strategies. Maintain excellent scientific standing among peers and the ability to address issues with an extremely high level of scientific rigor and creative solutions.

• Develop a world-class ophthalmology medical affairs team comprised of HQ and field-based personnel; ensure that our medical team is being challenged and developed to be ready to take on new roles and programs as the pipeline evolves.
• Represents REGN Medical Affairs at joint commercialization committee(s) with our alliance partner(s) where relevant.
• Provide leadership to ensure that the ophthalmology medical affairs team creates, measures and reports outcome-based value for the benefit of internal and external stakeholders.
• Responsible for the timely planning and execution of medical affairs strategies addressing the development and/or commercialization needs for pipeline and commercialized products. Accountable to synthesize strategies and apply a patient-first Clinical Impact Opportunity framework to formulate asset/indication specific Medical Impact Plans.
• Development and cultivation of long-term strategic partnerships with clinical experts, societies, collaborative groups, advocacy groups, and other external stakeholders representing Regeneron.

This role may be for you if you have the following:

• M.D. Board-certified ophthalmologist with a strong